rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Anh Tu Nguyen

Officer

Company insider

Files Form 4 as: Officer, Xeris Biopharma Holdings.

In numbers

Trades disclosed
6
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
30 Jan 2026
Last trade
24 Feb 2026
Last filed
25 Feb 2026

Companies traded

Where they are an officer
XERS Xeris Biopharma HoldingsOfficer · Biotechnology · last 24 Feb 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
24 Feb 2026filed 25 Feb 2026XERS Xeris Biopharma HoldingsBiotechnologySEC FORM 4 Code F$202K29,300 at $6.88filing
24 Feb 2026filed 25 Feb 2026XERS Xeris Biopharma HoldingsBiotechnologySEC FORM 4 Code F$202K29,300 at $6.88filing
30 Jan 2026filed 2 Feb 2026XERS Xeris Biopharma HoldingsBiotechnologySEC FORM 4 Code A—121,293 at $0.00filing
30 Jan 2026filed 2 Feb 2026XERS Xeris Biopharma Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—162,162 at $0.00filing
30 Jan 2026filed 2 Feb 2026XERS Xeris Biopharma Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—162,162 at $0.00filing
30 Jan 2026filed 2 Feb 2026XERS Xeris Biopharma HoldingsBiotechnologySEC FORM 4 Code A—121,293 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Kevin McCullochOfficer · Officer at Xeris Biopharma Holdings, filing Form 4 there in the last year
Beth HechtOfficer · Officer at Xeris Biopharma Holdings, filing Form 4 there in the last year
Steven PieperOfficer · Officer at Xeris Biopharma Holdings, filing Form 4 there in the last year
John Patrick Shannon Jr.Director and Officer · Director and Officer at Xeris Biopharma Holdings, filing Form 4 there in the last year
Nerissa KreherDirector · Director at Xeris Biopharma Holdings, filing Form 4 there in the last year